Vitreoretinal surgery using Transconjunctival Sutureless Vitrectomy

This report presents the effectiveness of 25-gauge Transconjunctival Sutureless Vitrectomy (TSV) for various vitreoretinal disorders. We performed vitreoretinal surgery on 6 patients using 25-gauge TSV. Minimal or no leakage of intraocular fluid or gas was observed at the entry site. No case required a suture to close the conjunctival or scleral opening site, and no complications resulted from the opening site. Median preoperative visual acuity was 0.04 and median postoperative best corrected visual acuity (BCVA) with a mean follow-up of 12 weeks, was 0.45. Median preoperative intraocular pressure was 12.67mmHg, and median intraocular pressure on the first postoperative day was 15.67 mmHg. Because transconjunctival sutureless surgery is minimally invasive, it increases the efficiency of vitrectomy, hastens postoperative recovery, and improves outcomes due to the simplified surgical procedure. We feel that the adoption of the 25-gauge TSV would lead to improved patient comfort, care, and management. reduced surgical time, reduced postoperative inflammation, and faster postoperative recovery(7-14) Moreover, the 25-gauge Transconjunctival Sutureless Vitrectomy (TSV) operating system, allows self-sealing transconjunctival sclerotomies. Sutureless closed vitrectomy is made possible by TSV, obviating conjunctival periotomy.(15-17) In this report, we present 6 cases of vitreoretinal surgery by 25-gauge TSV, and demonstrate its potential to increase the efficiencies of various vitreoretinal surgeries.